ÂÜÀòÂÒÂ×

Korie Osborn has extensive work experience in the pharmaceutical industry. They have held various positions at different companies, including Azurity Pharmaceuticals, Silvergate Pharmaceuticals, Inc., Cardinal Health Regulatory Sciences, Acceleration Laboratory Services, Inc., Aptuit, and Pfizer.

At Azurity Pharmaceuticals, Korie currently serves as the Vice President of Regulatory Affairs. In their previous role at the same company, they were the Director of Regulatory Affairs. In these positions, Korie was responsible for the development and implementation of regulatory strategies and tactics. They also oversaw the preparation, review, and finalization of scientific and regulatory documents associated with pre-approval pipeline and commercial products.

Before joining Azurity, Korie worked as the Director of Quality Assurance at Silvergate Pharmaceuticals, Inc. They were responsible for ensuring quality standards and compliance.

At Cardinal Health Regulatory Sciences, Korie held two roles. First, they served as a Senior Scientist, providing consulting services and overseeing regulatory strategies for CMC product development programs. Later, they worked as a Manager of Quality Assurance, where they partnered with healthcare providers and pharmaceutical manufacturers to improve specialty care.

Prior to Cardinal Health, Korie worked at Acceleration Laboratory Services, Inc. in various quality assurance positions, including Director of Quality Assurance and Quality Assurance Manager. They also worked as a Quality Assurance Auditor.

Korie's early career began at Aptuit, where they served as the Manager of Microbiology. They also gained experience at Pfizer, initially as a Microbiologist and later as a Quality Assurance Coordinator.

Overall, Korie Osborn has a diverse background in regulatory affairs, quality assurance, and microbiology within the pharmaceutical industry.

Korie Osborn completed a Bachelor of Science degree in Biology and Chemistry from the University of Central Missouri from 1995 to 1999. Later, from 2005 to 2007, they pursued an MBA degree in Business from Baker University.